Angiotension-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness

European Journal of Pharmacology

Volumn 337, Issue 2-3, 1997, Pages 259-265

  Matsubara, Shigeki ^a   Kikkawa, Hideo ^a   Kaminuma, Osamu ^a   Ikezawa, Katsuo ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Airway hyperresponsiveness; Angiotensin converting enzyme; Captopril; Enalapril; Imidapril; Ozone

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENZYME INHIBITOR; IMIDAPRIL; OZONE; IMIDAZOLE DERIVATIVE; IMIDAZOLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG POTENTIATION; LUNG FUNCTION TEST; PATHOPHYSIOLOGY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRONCHIAL HYPERREACTIVITY; CAPTOPRIL; DRUG SYNERGISM; ENALAPRIL; GUINEA PIGS; IMIDAZOLES; IMIDAZOLIDINES; MALE; OZONE; RESPIRATORY FUNCTION TESTS;

EID: 0030608744     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01316-2     Document Type: Article

References (34)

1. Barnes P.J. Asthma as an axon reflex. Lancet. i:1986;242-245.
2. Bucknall C.E., Neilly J.B., Carter R., Stevenson R.D., Semple P.F. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. Br. Med. J. 296:1988;86-88.
3. Coulter D.M., Edwards I.R. Cough associated with captopril and enalapril. Br. Med. J. 294:1987;1521-1523.
4. Forsberg K., Karlsson J.-A. Cough induced by stimulation of capsaicin-sensitive sensory neurons in conscious guinea-pigs. Acta Physiol. Scand. 128:1986;319-320.
5. Fox A.J., Lalloo U.G., Belvisi M.G., Bernareggi M., Chung K.F., Barnes P.J. Bradykinin-evoked sensitization of airway sensory nerves: A mechanism for ACE-inhibitor cough. Nature Med. 2:1996;814-817.
6. Fuller R.W., Choudry N.B. Increased cough reflex associated with angiotensin converting enzyme inhibitor cough. Br. Med. J. 295:1987;1025-1026.
7. Ito K., Ito K., Sawada Y., Kamei J., Misawa M., Iga T. Toxicodynamic analysis of cough and inflammatory reactions by angiotensin-converting enzyme inhibitors in guinea pig. J. Pharmacol. Exp. Ther. 275:1995;920-925.
8. Jaspard E., Wei L., Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). J. Biol. Chem. 268:1993;9496-9503.
9. Kaufman J., Casanova J.E., Riendl P., Schlueter D.P. Bronchial hyperactivity and cough due to angiotensin-converting enzyme inhibitors. Chest. 95:1989;544-548.
10. Kawashima K., Mizuuchi H., Yamanaka K., Maki T., Banno K., Sato T., Miyata T., Takahama K. Pharmacokinetics of imidapril, a new angiotensin-converting enzyme inhibitor, in guinea pigs. Oyo-Yakuri. 48:1994;371-381. (Abstract in English).
11. Koto H., Aizawa H., Takata S., Inoue H., Hara N. An important role of tachykinins in ozone-induced airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 151:1995;1763-1769.
12. Krane N.K., Walling J.D. Managing the elderly patient with both hypertension and pulmonary disease. Geriatrics. 42:1987;45-52.
13. Kubo M., Ochiai T., Kato J., Ishida R. Pharmacological studies on TA-6366, a new ACE inhibitor: II. Effect of long-term administration from the pre-hypertensive stage on blood pressure, relative heart weight and ACE activity of various tissues in spontaneously hypertensive rats (SHRs). Jpn. J. Pharmacol. 57:1991;517-526.
14. Lindgren B.R., Andersson R.G.G. Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. Med. Toxicol. Adverse Drug Exp. 4:1989;369-380.
15. Lindgren B.R., Anderson C.D., Andersson R.G.G. Potentiation of inflammatory reactions in guinea-pig skin by an angiotensin converting enzyme inhibitor (MK 422). Eur. J. Pharmacol. 135:1987;383-387.
16. Lindgren B.R., Persson K., Kihlström J.-E., Andersson R.G.G. ACE-inhibitor-induced enhancement of spontaneous and IgE-mediated histamine release from mast cells and basophilic leukocytes and the modulatory effect of capsaicin sensitive nerves. Pharmacol. Toxicol. 64:1989;159-164.
17. Matsubara S., Fushimi K., Kaminuma O., Kikkawa H., Shimazu N., Iwasaki H., Ikezawa K. Importance of impairment of the airway epithelium for ozone-induced airway hyperresponsiveness in guinea pigs. Jpn. J. Pharmacol. 67:1995;375-382.
18. Matsubara S., Fushimi K., Kaminuma O., Kikkawa H., Ikezawa K., Naito K. Prevention of ozone-induced airway hyperresponsiveness and epithelial injury by phosphodiesterase inhibitors in guinea pigs. Environ. Toxicol. Pharmacol. 3:1997;201-209.
19. Murata T., Matsumoto Y., Kashida T., Kaminuma O., Naito K., Ikezawa K., Tsuzurahara K. Difference among angiotensin-converting enzyme inhibitors in potentiating effects on bradykinin-induced microvascular leakage in guinea pig airways. Jpn. J. Pharmacol. 69:1995;111-118.
20. 3. Lung. 171:1993;109-121.
21. Ogihara T., Mikami H., Katahira K., Otsuka A. Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex. Am. J. Hypertens. 4:1991;46S-51S.
22. Okamura T., Kitamura Y., Kimura T., Toda N. Comparison of selective actions of imidaprilat and enalaprilat on the response to angiotensin I and bradykinin in isolated dog blood vessels. Oyo-Yakuri. 46:1993;427-436. (Abstract in English).
23. Popa V. Captopril-related (and -induced?) asthma. Am. Rev. Respir. Dis. 136:1987;999-1000.
24. Saria A., Martling C.-R., Yan Z., Theodorsson-Norheim E., Gamse R., Lundberg J.M. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium and vagal nerve stimulation. Am. Rev. Respir. Dis. 137:1988;1330-1335.
25. Saruta T., Omae T., Kuramochi M., Iimura O., Yoshinaga K., Abe K., Ishii M., Watanabe T., Takeda T., Ito K., Kokubo T., Fujishima M., Arakawa K., Nakajima M. Imidapril hydrochloride in essential hypertension: A double-blind comparative study using enalapril maleate as a control. J. Hypertens. 13 (Suppl.):1995;S23-30.
26. Sasaguri M., Ideishi M., Kinoshita A., Arakawa K. Difference in inhibitory potency of bradykinin hydrolysis of ACE inhibitors might cause difference in cough incidence. J. Hypertens. 12 (Suppl.):1994;S95.
27. Sumikawa H., Ogiku N., Hashimoto Y., Kudo Y., Ishida R. Study on cough-potentiating effect of imidapril, a new ACE inhibitor, in guinea pigs. Jpn. Pharmacol. Ther. 20:1992;13-19. (Abstract in English).
28. Takahama K., Araki T., Fuchikami J., Kohjimoto Y., Miyata T. Studies on the magnitude and the mechanism of cough potentiation by angiotensin-converting enzyme inhibitors in guinea pigs: Involvement of bradykinin in the potentiation. J. Pharm. Pharmacol. 48:1996;1027-1033.
29. Tepper J.S., Costa D.L., Fitzgerald S., Doerfler D.L., Bromberg P.A. Role of tachykinins in ozone-induced acute lung injury in guinea pigs. J. Appl. Physiol. 75:1993;1404-1411.
30. Tobian L., Brunner H.R., Cohn J.N., Gavras H., Laragh J.H., Materson B.J., Weber M.A. Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am. J. Hypertens. 7:1994;859-872.
31. Turner A.J., Matsas R., Kenny A.J. Are there neuropeptide-specific peptidases? Biochem. Pharmacol. 34:1985;1347-1356.
32. Wei L., Alhenc-Gelas F., Corvol P., Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266:1991;9002-9008.
33. Wei L., Clauser E., Alhenc-Gelas F., Corvol P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267:1992;13398-13405.
34. Ziment I. Management of hypertension in the asthmatic patient. Chest. 83 (Suppl.):1983;392-395.